Incubate Joins Bipartisan Chorus: March-In Proposal Is Bad Policy
Read Incubate's blog on the recently announced March-In proposal. Incubate recently submitted a comment letter intended to educate...
top of page
Incubate Coalition
Jan 24
2024 Open Letter On Life Sciences Policy
An Open Letter to Members of Congress and the Biden Administration from Leaders in the Life Sciences Community As leaders... An Open...
Incubate Coalition
Jan 21
Incubate And DLA Piper Host Breakfast Panel At JPM24
Incubate and DLA Piper hosted a breakfast panel at this year's J.P. Morgan Healthcare Conference in San Francisco, California. Incubate...
Incubate Coalition
Dec 7, 2023
Life Sciences Investors React To Biden Administration’s March-In Decision
After a nine-month review, the Biden administration has reached the unprecedented and misguided conclusion that the 1980 Bayh-Dole Act...
Incubate Coalition
Sep 18, 2023
Medicare Presses Forward With Drug Price Setting
In late August, the Centers for Medicare & Medicaid Services announced the first 10 drugs that will be subject to Medicare price setting...
Incubate Coalition
Sep 15, 2023
Mohit Manrao Talks Small-Molecule Penalty, Eliminating Cancer As A Cause Of Death, And More
The small-molecule penalty "doesn't create the right incentives for where we want to go with the Cancer Moonshot or driving cures," Mohit...
Incubate Coalition
Mar 31, 2023
Incubate Testifies At USITC Hearing
Executive Director John Stanford testified before the International Trade Organization.
Incubate Coalition
Feb 18, 2021
Mergers And Acquisitions: A Key Driver Of VC Investment In Healthcare
The drug pricing debate is a worthy one. We have to have open discussions about maximizing innovation and access. But half-written...
bottom of page